ConductScience.org, home
Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)
API referenceFor AI assistants

Trial · NCT00637377

Participant flow20

How many started, completed or left each group, period by period.

1 to 20 of 20

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDRanibizumab 0.5mg Q4303
Overall StudySTARTEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q4313
Overall StudySTARTEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 0.5mg Q4311
Overall StudySTARTEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q8313
Overall StudyParticipants Received TreatmentRanibizumab 0.5mg Q4291
Overall StudyParticipants Received TreatmentAflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q4309
Overall StudyParticipants Received TreatmentAflibercept Injection (EYLEA, VEGF Trap-Eye) 0.5mg Q4297
Overall StudyParticipants Received TreatmentAflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q8307
Overall StudyParticipants Treated (FAS)Ranibizumab 0.5mg Q4291
Overall StudyParticipants Treated (FAS)Aflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q4309
Overall StudyParticipants Treated (FAS)Aflibercept Injection (EYLEA, VEGF Trap-Eye) 0.5mg Q4296
Overall StudyParticipants Treated (FAS)Aflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q8306
Overall StudyCOMPLETEDRanibizumab 0.5mg Q4276
Overall StudyCOMPLETEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q4281
Overall StudyCOMPLETEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 0.5mg Q4274
Overall StudyCOMPLETEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q8284
Overall StudyNOT COMPLETEDRanibizumab 0.5mg Q427
Overall StudyNOT COMPLETEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q432
Overall StudyNOT COMPLETEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 0.5mg Q437
Overall StudyNOT COMPLETEDAflibercept Injection (EYLEA, VEGF Trap-Eye) 2mg Q829

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00637377/flow

API referenceFor AI assistants